Bye, AP; Kriek, N; Sage, T; Rawlings, SJ; Prodger, C; Kesavan, M; Lees, C; Booth, S; Cowen, LG; Shefferd, K; et al. Bye, AP; Kriek, N; Sage, T; Rawlings, SJ; Prodger, C; Kesavan, M; Lees, C; Booth, S; Cowen, LG; Shefferd, K; Desborough, MJ; Gibbins, JM; Eyre, TA (2023) Pirtobrutinib results in reversible platelet dysfunction compared to ibrutinib and acalabrutinib. Haematologica, 108 (5). ISSN 1592-8721 https://doi.org/10.3324/haematol.2022.281402
SGUL Authors: Bye, Alexander Paul

Preview	PDF Published Version Available under License Creative Commons Attribution Non-commercial. Download (885kB) | Preview
	Microsoft Word (.docx) Accepted Version Restricted to Repository staff only Available under License ["licenses_description_unknown" not defined]. Download (834kB)

Item Type:	Article
Keywords:	1102 Cardiorespiratory Medicine and Haematology, Immunology
SGUL Research Institute / Research Centre:	Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title:	Haematologica
ISSN:	1592-8721
Language:	eng
Dates:	Date Event May 2023 Published 15 December 2022 Published Online
Publisher License:	Creative Commons: Attribution-Noncommercial 4.0
Projects:	Project ID Funder Funder ID RG/20/7/34866 British Heart Foundation http://dx.doi.org/10.13039/501100000274 StGeorges-21\1 Rosetrees Trust http://dx.doi.org/10.13039/501100000833 UNSPECIFIED National Institute for Health Research http://dx.doi.org/10.13039/501100000272
PubMed ID:	36519322
	Go to PubMed abstract
URI:	https://openaccess.sgul.ac.uk/id/eprint/115162
Publisher's version:	https://doi.org/10.3324/haematol.2022.281402

Actions (login required)

Edit Item